I'm interested in any interpretation of the comments in the last announcement. Who will do this further testing? Will the Doherty Institute keep performing these experiments? I'm assuming so when they said "look forward to coming studies". It seems the need to have something to curtail these new Covid strains is urgent.
Further testing will be required at higher dose levels to establish the IC 50 and cytotoxicity which will then allow the Company to decide whether to pursue R327 as an anti SARS-CoV2 inhibitor candidate........We would like to thank the Doherty Institute for performing the experiments and look forward to coming studies”
- Forums
- ASX - By Stock
- RCE
- Ann: Further Encouraging COVID Results at Doherty
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

Ann: Further Encouraging COVID Results at Doherty, page-34
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online